The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. This year’s metric has recorded a Price decrease of -23.88%. However, over the past six months, we’ve seen a stronger performance of -17.49%. The price of DVAX leaped by -22.18% over the last 30 days. And in the last five days, it has fallen by -17.28%.
The market performance of Dynavax Technologies Corp’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $14.63 on 03/07/25, while the lowest value for the same duration was $9.74 on 05/07/25.
52-week price history of DVAX Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Dynavax Technologies Corp’s current trading price is -33.56% away from its 52-week high, while its distance from the 52-week low is -0.21%. The stock’s price range during this period has varied between$9.74 and $14.63. The Dynavax Technologies Corp’s shares, which operate in the Healthcare, saw a trading volume of around 6.23 million for the day, a figure considerably higher than their average daily volume of 2.56 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Dynavax Technologies Corp (DVAX) has experienced a quarterly decline of -26.14% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.19B and boasts a workforce of 405 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 12.70, with a change in price of -3.13. Similarly, Dynavax Technologies Corp recorded 2,265,819 in trading volume during the last 100 days, posting a change of -24.36%.
DVAX’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for DVAX stands at 0.55. Similarly, the long-term debt-to-equity ratio is also 0.54.
DVAX Stock Stochastic Average
As of today, Dynavax Technologies Corp’s raw stochastic average for the last 50 days stands at 2.00%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 3.80%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 25.98% and 36.93%, respectively.
